Evidence map›Paper›PMID 42572062›Full record

ArticleEJNMMI reports2026

Precise localization of phosphaturic mesenchymal tumor causing tumor-induced osteomalacia: the value of dual-tracer imaging with ¹⁸F-FDG and ⁶⁸Ga-DOTATATE PET/CT.

Ting Ye, Xin Wen, Ruimin Wang

Abstract read
In one paragraph

Article in EJNMMI reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ting YeDepartment of Nuclear Medicine, The First Medical Center, Chinese PLA General Hospital, Beijing, 100853, China.
Xin WenDepartment of Nuclear Medicine, The First Medical Center, Chinese PLA General Hospital, Beijing, 100853, China.
Ruimin WangDepartment of Nuclear Medicine, The First Medical Center, Chinese PLA General Hospital, Beijing, 100853, China. wrm@yeah.net.ORCID http://orcid.org/0000-0001-9948-2633

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phosphaturic mesenchymal tumor (PMT) is a rare cause of tumor-induced osteomalacia (TIO), often presenting with nonspecific symptoms and small tumor size, leading to diagnostic challenges. We report a case of a 25-year-old male with progressive generalized bone pain, hypophosphatemia, and elevated alkaline phosphatase, initially misdiagnosed as spondyloarthritis and osteoporosis. Whole-body bone scintigraphy suggested metabolic bone disease.

Indexed as

18F-FDG⁶⁸Ga-DOTATATEHypophosphatemiaPET/CTPhosphaturic mesenchymal tumorTumor-induced osteomalacia

Identifiers

PMID42572062
PMCPMC13454022

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.